Literature DB >> 826813

[Tick-borne meningopolyneuritis (Garin-Bujadoux, Bannwarth)].

R Ackermann.   

Abstract

The meningopolyneuritis first described in 1922 by Garin and Bujadoux develops after a tick bite. At the site of the bite in some of the cases, erythema chronicum migrans develops first. Severe pains follow in this area which may spread to other parts of the body. Then peripheral paralysis appears with asymmetrical distribution. The motor cerebral nerves, especially the facial nerve, are also frequently affected. Mild sensitivity disorders occur with no systematic arrangement. There is a lymphocyte pleocytosis of 100-2600/3 mm3 and an increase in protein of varying intensity, meningeal symptoms usually being absent. The disease persists for 3-5 months. Apart from rare residual, the prognosis is favorable.

Entities:  

Mesh:

Year:  1976        PMID: 826813

Source DB:  PubMed          Journal:  MMW Munch Med Wochenschr        ISSN: 0341-3098


  5 in total

1.  Neuropathy of vasculitic origin in a case of Garin-Boujadoux-Bannwarth syndrome with positive borrelia antibody response.

Authors:  F Camponovo; C Meier
Journal:  J Neurol       Date:  1986-04       Impact factor: 4.849

2.  Histopathological findings in the central and peripheral nervous systems in neuroborreliosis. A report of three cases.

Authors:  B Meurers; W Kohlhepp; R Gold; E Rohrbach; H G Mertens
Journal:  J Neurol       Date:  1990-04       Impact factor: 4.849

3.  Cerebrospinal fluid immunoglobulins and virus-specific antibodies in disorders affecting the facial nerve.

Authors:  T Weber; S Jürgens; W Lüer
Journal:  J Neurol       Date:  1987-06       Impact factor: 4.849

4.  [Characteristic cerebrospinal fluid findings and clinical aspects of lymphocytic meningoradiculitis].

Authors:  C R Hornig; O Busse; W Dorndorf
Journal:  Klin Wochenschr       Date:  1984-01-02

5.  Are CSF or serum ganglioside antibodies related to peripheral nerve demyelination in neuroborreliosis, Guillain-Barré syndrome, or chronic inflammatory demyelinating polyradiculoneuropathy?

Authors:  M Weller; A Stevens; N Sommer; H Wiethölter
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  1992       Impact factor: 5.270

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.